VIA Pharmaceuticals, Inc. Stock Other OTC
Equities
VIAP
US92554T1034
Biotechnology & Medical Research
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2009 | -21M | Net income 2010 | -9M | EV / Sales 2009 | - |
Net Debt 2009 | 7.81M | Net Debt 2010 | 13.92M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.19
x | P/E ratio 2010 |
-0.08
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |